Close
Apr 29, 2024 10:21AM
Apr 29, 2024 10:11AM
Apr 29, 2024 09:59AM
Apr 29, 2024 09:39AM
Apr 29, 2024 09:02AM
Apr 29, 2024 09:01AM
Apr 29, 2024 09:00AM GE HealthCare (GEHC) Granted FDA Clearance for Portrait VSM
Apr 29, 2024 08:45AM
Apr 29, 2024 08:02AM
Apr 29, 2024 08:02AM
Apr 29, 2024 08:01AM
Apr 29, 2024 08:01AM
Apr 29, 2024 08:00AM
Apr 29, 2024 07:58AM ZyVersa Therapeutics (ZVSA) Reports Publication Reinforcing the Rationale for Inhibiting ASC with IC 100 to Potentially Attenuate Cardiac Comorbidities
Apr 29, 2024 07:42AM
Apr 29, 2024 07:32AM
Apr 29, 2024 07:06AM
Apr 29, 2024 07:05AM
Apr 29, 2024 07:03AM
Apr 29, 2024 07:01AM
Apr 29, 2024 07:01AM Labcorp (LH) Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B
Apr 29, 2024 06:45AM
Apr 29, 2024 06:31AM
Apr 29, 2024 06:30AM
Apr 29, 2024 06:05AM
Apr 29, 2024 06:02AM
Apr 29, 2024 05:52AM
Apr 29, 2024 05:51AM AstraZeneca (AZN) reports Enhertu's statistically significant and clinically meaningful improvement in progression-free survival in in DESTINY-Breast06 Phase III trial
Apr 26, 2024 11:44AM
Apr 26, 2024 08:32AM
Apr 26, 2024 08:31AM
Apr 26, 2024 08:03AM
Apr 26, 2024 07:57AM
Apr 26, 2024 07:23AM
Apr 26, 2024 07:16AM Apellis' (APLS) Pegcetacoplan MAA Review Has Been Reset to Day 180 of Initial Assessment by EMA
Apr 25, 2024 04:41PM
Apr 25, 2024 04:25PM
Apr 25, 2024 04:20PM
Apr 25, 2024 04:07PM
Apr 25, 2024 09:29AM
Apr 25, 2024 08:32AM
Apr 25, 2024 08:29AM AbbVie (ABBV): New Data Show RINVOQ Demonstrated Superiority Versus DUPIXENT Across Primary and All Secondary Endpoints
Apr 25, 2024 07:30AM
Apr 25, 2024 07:03AM
Apr 25, 2024 07:01AM
Apr 25, 2024 06:55AM
Apr 25, 2024 05:55AM
Apr 24, 2024 04:01PM
Apr 24, 2024 09:25AM Gain Therapeutics (GANX) Announces Positive Results from the Single Ascending Dose (SAD) Part of the Phase 1 Clinical Trial of GT-02287
Apr 24, 2024 09:00AM

66,927 total articles have been posted to this category.

Sign-up to StreetInsider.com Premium to see all today's market moving FDA reports.